Lilly''s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight (news.google.com)
PARAMOUNT REAFFIRMS COMMITMENT TO DELIVERING SUPERIOR 30 PER SHARE ALL-CASH OFFER TO WARNER BROS. DISCOVERY SHAREHOLDERS - Investor Relations Paramount (news.google.com)
Austin-Bergstrom International Airport and Airline Partners Finalize Historic Use and Lease Agreements to Support Multi-Billion-Dollar Expansion Program (news.google.com)
GSK announces positive results from B-Well 1 and B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B (news.google.com)
DoorDash’s CEO blasts ‘appalling’ claim that a major delivery app gives drivers a desperation score: ‘I would fire anyone who tolerated this’ (news.google.com)